Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C

INTRODUCTION: Hepatitis C virus (HCV) infection is one of the principle causes of chronic liver disease. Successful treatment significantly decreases the risk of hepatic morbidity and mortality. Current standard of care achieves sustained virologic response (SVR) rates of 40–80%; however, the HCV th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: McEwan, Phil, Ward, Thomas, Bennett, Hayley, Kalsekar, Anupama, Webster, Samantha, Brenner, Michael, Yuan, Yong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311930/
https://ncbi.nlm.nih.gov/pubmed/25635922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0117334
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia